gquadruplex
nucleic
acid
secondari
structur
may
form
singlestrand
grich
sequenc
physiolog
four
gs
bind
via
hoogsteentyp
hydrogen
bond
basepair
yield
gquartet
turn
stack
top
form
structur
may
significantli
vari
term
strand
stoichiometri
form
inter
intramolecular
structur
strand
orientationtopolog
presenc
k
cation
specif
support
format
human
genom
prokaryot
dna
motif
found
telomer
grich
micro
minisatellit
near
oncogen
promot
within
human
dna
motif
report
associ
recombin
prone
show
mutat
pattern
preserv
potenti
form
dna
misregul
structur
associ
relev
human
neurolog
identif
bind
visual
cell
antibodybas
also
provid
convinc
evid
exist
cellular
vivo
recent
presenc
virus
involv
viru
key
step
also
implic
pathogen
mechan
sar
group
identifi
function
signific
nef
code
uniqu
long
termin
repeat
ltr
human
immunodefici
viru
hiv
etiolog
agent
acquir
immun
defici
syndrom
aid
studi
shown
fold
ltr
promot
decreas
viral
transcript
effect
augment
involv
structur
sever
human
diseas
propel
develop
ligand
sever
aromat
core
proton
side
chain
bind
conform
acridin
scheme
anthraquinon
phenanthrolin
quinacridin
carbazol
bisindol
carboxamid
triazol
benzimidazol
natur
compound
deriv
sever
tetrasubstitut
perlyen
watersolubl
naphthalen
diimid
ndi
far
vast
major
molecul
test
cellular
implic
tumor
pathogenesi
compound
show
interest
antiprolif
properti
particular
quarfloxin
proceed
phase
ii
clinic
trial
limit
bioavail
prevent
molecul
test
also
antivir
despit
low
select
index
studi
shown
possibl
develop
antivir
molecul
gquadruplexmedi
mechan
action
later
expans
ndi
core
provid
investig
may
offer
addit
opportun
enhanc
bind
potenc
select
discrimin
structur
differ
access
edg
quartet
exampl
compris
annul
five
sixmemb
heterocycl
ring
either
one
side
side
report
scheme
surprisingli
one
class
coreextend
ndi
cexndi
engin
watersolubl
investig
other
found
applic
field
materi
chemistri
ph
possibl
block
transcript
stabil
structur
present
uniqu
viral
ltr
promot
synthes
test
seri
novel
cexndi
bind
ltr
activ
new
structur
ndi
core
merg
dihydrobenzophenazin
polynuclear
heterocycl
highlight
red
scheme
prove
deriv
display
bind
stabil
select
toward
viral
compar
telomer
translat
therapeut
window
compound
activ
viru
toxic
cell
design
synthes
small
librari
new
watersolubl
cexndi
scheme
ndi
core
merg
dihydrobenzophenazin
polynuclear
heterocycl
highlight
red
scheme
choic
made
base
pka
valu
n
ndimethylpropanamin
side
chain
pka
valu
suggest
side
chain
mainli
proton
physiolog
condit
aspect
ensur
good
solubil
properti
reduc
selfaggreg
discharg
shorter
n
ndimethylthylamin
side
chain
pka
valu
much
lower
cexndi
structur
character
larger
flat
core
ndi
featur
improv
interact
implement
bind
inde
dft
calcul
perform
p
level
theori
ga
phase
indic
dimens
cexndi
core
support
extens
overlap
quartet
structur
support
inform
figur
enhanc
ligand
steric
hindranc
access
outsid
quartet
might
offer
opportun
implement
select
well
furthermor
propos
structur
extens
ndi
scaffold
merg
use
optoelectron
properti
absorpt
emiss
singlet
oxygen
sensit
function
ndi
substitut
dihydrobenzophenazin
compound
h
br
substitu
posit
consid
evalu
effect
bulki
substitu
br
posit
synthes
cexndi
develop
synthet
protocol
highlight
scheme
accord
publish
method
imid
reaction
readili
avail
dianhydrid
yield
ndi
acid
condit
almost
quantit
yield
subsequ
twostep
protocol
start
nucleophil
aromat
substitut
snar
presenc
excess
equiv
orthodiaminophenyl
deriv
dmf
solvent
h
afford
mixtur
monobromin
debromin
product
overal
quantit
yield
ring
close
reaction
follow
snar
one
pot
step
scheme
occur
tchitchibabin
mechan
elimin
hydrid
favor
format
sixmemb
ring
second
snar
remain
aromat
bromid
carri
dissolv
neat
improv
reaction
yield
optim
microwaveassist
protocol
psi
bar
w
min
seal
reaction
vessel
give
product
crystal
reaction
mixtur
achiev
synthesi
perman
charg
quaternari
ammonium
salt
classic
exhaust
methyl
presenc
mei
rt
h
synthes
ligand
purifi
prepar
hplc
eluent
anion
exchang
yield
hydrochlorid
salt
contrari
investig
iodid
quaternari
ammonium
salt
detect
abil
new
cexndi
bind
stabil
conform
ltr
promot
two
ltr
sequenc
employ
ltriii
ltriv
compos
four
ggg
tract
figur
embed
within
fulllength
grich
sequenc
ltr
promot
ltriii
stabl
ltriv
fold
induc
fret
melt
assay
perform
assess
degre
stabil
ltriii
ltriv
cexndi
minim
intramolecular
human
telomer
htel
sequenc
figur
employ
evalu
activ
cexndi
one
highli
repres
access
cellular
fact
ttaggg
repeat
present
doublestrand
ds
singlestrand
sequenc
human
doublestrand
ds
dna
also
ad
address
specif
toward
conform
support
inform
tabl
kind
assay
typic
perform
use
molar
excess
test
compound
initi
employ
equimolar
amount
target
dna
sequenc
compound
ie
better
differenti
stabil
effici
among
differ
cexndi
melt
temperatur
ltriii
ltriv
htel
dsdna
conform
suffici
similar
respect
allow
meaning
comparison
presenc
cexndi
mark
increas
stabil
oligonucleotid
observ
figur
support
inform
tabl
among
test
cexndi
effici
ligand
stabil
ltriv
equimolar
amount
cexndi
dna
molar
ratio
stabil
increas
maximum
increas
measur
set
data
shown
cexndi
show
intermedi
low
level
stabil
ltriv
compound
stabil
ltriii
among
structur
htel
least
effici
stabil
wherea
stabil
dsdna
neglig
compound
display
signific
stabil
dsdna
indic
presenc
two
perman
charg
quaternari
ammonium
moieti
favor
unspecif
bind
neg
charg
nucleic
acid
gener
h
seri
deriv
h
scheme
activ
select
viral
compar
br
substitut
one
br
scheme
compound
exhibit
differ
stabil
ltriv
vs
htel
equal
roughli
correspond
overal
stabil
effici
figur
support
inform
tabl
oligonucleotid
use
fret
analysi
display
fluorophoremodifi
end
may
influenc
measur
stabil
addit
techniqu
use
labelfre
oligonucleotid
employ
compound
repres
best
ligand
assay
circular
dichroism
cd
ltriv
ltriii
htel
cexndi
dna
ratio
stabil
higher
obtain
ltriii
ltriv
support
inform
figur
htel
stabil
support
inform
figur
confirm
prefer
viral
taq
polymeras
stop
assay
perform
ltriii
ltriv
htel
templat
control
templat
unabl
fold
use
exclud
unspecif
inhibit
polymeras
enzym
cexndi
compound
induc
intens
stop
site
g
tract
templat
figur
indic
effect
stabil
conform
compound
effect
significantli
relev
viral
sequenc
vs
telomer
templat
figur
confirm
preferenti
stabil
viral
techniqu
evalu
stabil
conform
indic
effici
interact
ligand
test
structur
bind
affin
next
directli
assess
two
differ
method
competit
electrospray
ioniz
mass
spectrometri
esim
allow
establish
rel
affin
cexndi
toward
sequenc
first
confirm
cd
analysi
buffer
condit
use
esim
experi
topolog
oligonucleotid
significantli
modifi
support
inform
figur
equimolar
amount
ltriiihtel
ltrivhtel
ltriiiltriv
incub
molar
excess
compound
esim
transfer
intact
biomolecul
complex
ga
phase
signal
intens
proport
abund
speci
solut
ratio
mz
signal
bound
speci
correspond
bound
free
figur
calcul
tabl
ltriii
ltriv
detect
mostli
allbound
speci
htel
mostli
unbound
figur
support
inform
figur
analysi
clearli
show
cexndi
preferenti
bind
two
viral
sequenc
telomer
sequenc
corrobor
select
toward
viral
sequenc
two
addit
cellular
fold
sequenc
evalu
ltr
prefer
compound
case
cmyc
compound
preferenti
bound
ltr
wherea
compound
show
intens
bind
cmyc
tabl
therefor
confirm
gener
even
though
absolut
select
toward
ltr
also
possibl
much
higher
stabil
cmyc
tm
vs
stabil
test
ltriii
ltriv
play
role
result
two
ltr
compet
ltriii
sequenc
prefer
excess
compound
ltriii
bound
two
molecul
compound
wherea
one
molecul
obtain
ltriv
htel
figur
support
inform
figur
satur
concentr
molar
excess
three
molecul
bound
ltriii
wherea
two
molecul
could
bind
ltriv
htel
support
inform
figur
next
absolut
affin
measur
surfac
plasmon
reson
spr
toward
three
sequenc
analysi
confirm
ltriii
display
highest
bind
affin
kd
nm
follow
ltriv
kd
nm
htel
exhibit
lowest
affin
kd
nm
figur
support
inform
figur
bind
affin
br
deriv
substitu
posit
r
ltriv
next
assess
compound
kd
valu
similar
kd
nm
respect
display
increas
bind
affin
kd
nm
wherea
show
lowest
affin
kd
nm
respect
data
line
stabil
properti
observ
deriv
fret
cd
analysi
confirm
improv
reduc
recognit
properti
cexndi
exhibit
perman
dication
neutral
monocation
charg
state
respect
physiolog
condit
also
confirm
bulki
substitu
posit
ndi
core
scheme
highli
reduc
bind
wherea
group
posit
r
maintain
excel
bind
properti
scheme
reason
observ
bias
affin
ltr
sequenc
could
deriv
specif
bind
cexndi
structuralsequ
featur
share
ltr
end
evalu
protect
exert
compound
residu
ltr
clerocidin
cl
molecul
shown
alkyl
dna
singlestrand
g
c
abl
predict
structur
label
oligonucleotid
fold
treat
increas
amount
expos
cl
treat
piperidin
highlight
clalkyl
site
set
expect
visual
loop
base
bound
cexndi
basepair
gs
involv
gquartet
format
would
avail
cl
alkyl
independ
presenc
compound
nmr
structur
ltriv
solv
pdb
code
therefor
abl
assess
nucleotid
affect
presenc
cexndi
two
loop
structur
particular
actg
loop
base
protect
wherea
c
g
expos
c
base
expos
figur
structur
ltriii
solv
yet
howev
previou
data
indic
fold
differ
conform
main
one
like
one
depict
figur
detect
lowresolut
structur
case
observ
protect
c
base
actg
loop
figur
share
ltriv
sequenc
see
figur
three
addit
residu
c
c
g
protect
figur
protect
exposur
residu
indic
specif
interact
affect
ltr
site
interestingli
uniqu
ltr
loop
particular
actg
loop
share
ltriii
ltriv
absent
telomer
sequenc
involv
indic
like
moieti
induc
select
exclud
region
bound
cexndi
probabl
interact
site
less
stabl
dynam
clear
protectionexposur
could
observ
previous
shown
viral
promot
fold
dynam
stabil
conform
ligand
repress
viral
transcript
viru
product
infect
cell
concentr
requir
inhibit
viru
product
low
averag
select
index
si
given
cexndi
bindingstabil
select
observ
vitro
viral
vs
cellular
set
investig
activ
newli
synthes
cexndi
deriv
compound
entri
preliminarili
measur
phase
contrast
fluoresc
microscopi
take
advantag
bluecolor
cexndi
dye
nm
unsubstitut
red
fluoresc
emiss
nm
min
incub
compound
concentr
cell
support
inform
figur
next
treat
infect
cell
increas
amount
compound
measur
viru
product
concurr
cytotox
concentr
cexndi
condit
uninfect
cell
measur
mtt
assay
compound
test
strain
strain
result
report
tabl
compound
display
inhibitori
concentr
valu
nm
compound
display
promis
si
best
among
test
cexndi
wherea
si
valu
compound
around
superior
deriv
exhibit
low
activ
low
cytotox
show
worst
combin
low
activ
high
cytotox
si
also
evalu
rang
concentr
therapeut
window
tw
obtain
antivir
activ
parallel
less
cytotox
shown
figur
display
widest
tw
nm
also
show
interest
tw
valu
tw
concentr
like
mainli
monoanion
physiolog
condit
moieti
exhibit
pka
rang
tw
observ
tabl
final
contain
two
quaternari
ammonium
moieti
display
antivir
cytotox
activ
like
due
inabl
enter
cell
alreadi
shown
ndi
perman
posit
compound
also
test
bal
strain
strain
differ
tropism
case
valu
nm
obtain
si
h
deriv
tabl
note
h
seri
deriv
activ
br
substitut
one
moreov
compound
display
valu
higher
human
fibroblast
cell
line
report
compound
multipl
posit
charg
block
viral
entri
interf
rule
unspecif
mechan
action
cexndi
treat
tzmbl
cell
h
post
infect
pi
compound
test
viru
product
h
pi
signific
differ
activ
compound
observ
test
time
figur
zidovudin
azt
refer
drug
target
revers
transcriptas
display
behavior
similar
cexndi
maintain
activ
h
pi
contrast
dextran
sulfat
ds
refer
entri
exhibit
antivir
effect
ad
h
pi
figur
data
indic
initi
step
target
thu
activ
ataft
h
pi
ie
entri
process
occur
next
test
abil
reduc
activ
ltr
promot
egfp
report
assay
helatatiii
cell
cell
line
stabli
transfect
plasmid
embed
egfp
code
region
control
ltr
promot
cell
treat
increas
concentr
cexndi
intens
egfp
fluoresc
assess
fac
analysi
steadi
decreas
mean
level
egfp
observ
noncytotox
concentr
inhibit
figur
check
activ
cexndi
ltr
promot
specif
conform
two
point
mutat
abolish
fold
introduc
ltr
sequenc
ltr
wt
ltr
ltr
luciferas
report
plasmid
transient
transfect
cell
either
alon
presenc
increas
amount
compound
luciferas
signal
measur
import
inhibit
ltr
activ
observ
wt
ltr
inhibit
wherea
effect
detect
mutant
ltr
sequenc
figur
data
indic
inhibit
viral
promot
cexndi
shown
synthesi
bind
properti
antivir
activ
new
seri
ndi
deriv
extend
aromat
core
first
new
compound
display
improv
stabil
structur
substanti
increment
tm
valu
previous
report
ndi
featur
indic
expans
aromat
surfac
allow
effect
recognit
structur
may
due
extens
overlap
quartet
structur
infer
dimens
cexndi
core
evalu
dft
calcul
support
inform
figur
second
compound
exhibit
promis
antivir
activ
compar
best
antivir
show
improv
valu
low
nm
vs
low
rang
featur
may
deriv
select
observ
vitro
ltr
telomer
structur
viral
telomer
like
two
abund
dna
speci
cell
infect
therefor
preferenti
effect
viral
would
result
higher
antivir
activ
lower
cytotox
observ
cexndi
display
select
bind
affin
stabil
viral
two
ltr
ltriii
sequenc
effici
bound
measur
esim
spr
even
though
ltriii
nt
ltriv
nt
display
ident
number
gquartet
ltriii
offer
longer
loop
may
accommod
addit
molecul
therefor
may
display
increas
bind
affin
inde
satur
concentr
bind
three
cexndi
molecul
observ
esim
ltriii
compar
two
molecul
ltriv
addit
two
loop
ltriii
ltriv
shown
involv
cexndi
interact
footprint
analys
suggest
compound
interact
edg
gquartet
core
ndi
planar
aromat
surfac
extend
moieti
side
chain
interact
side
loop
afford
select
toward
ltr
knowledg
first
exampl
type
select
base
chemic
recognit
specif
residu
fact
previous
report
select
rather
reli
recognit
analysi
bind
activ
seri
cexndi
led
us
follow
relationship
sar
conclus
nonextend
side
cexndi
core
posit
scheme
lack
substitu
introduct
aminoalkyl
side
chain
highli
hinder
stabil
structur
ie
ii
br
allow
substitu
lower
bind
select
toward
viral
sequenc
br
group
may
hinder
specif
interact
henc
lower
select
partial
distort
aromat
core
planar
henc
lower
bind
iii
pyridin
ring
place
benzen
extend
core
strongli
detriment
compound
fair
antivir
activ
parallel
moder
cytotox
allow
tw
possibl
due
offtarget
activ
iv
moieti
allow
compound
compound
power
select
ligand
toward
ltriii
v
neg
charg
carboxyl
group
decreas
electrostat
compon
bind
dna
compound
vi
contrari
perman
posit
charg
ammonium
group
extens
increas
bind
target
ad
electrostat
interact
compound
howev
compound
perman
charg
suitabl
cell
entri
henc
exploit
antivir
purpos
scheme
chemic
properti
lead
highaffin
recognit
select
cexndi
binder
report
graphic
abstract
conclus
report
new
class
ligand
abl
discrimin
structur
base
chemic
recognit
structur
featur
uniqu
select
sequenc
one
hand
approach
open
possibl
develop
antihiv
compound
new
mechan
action
may
complement
current
clinic
aid
therapi
hand
work
clearli
highlight
possibl
select
recogn
structur
small
molecul
prompt
search
develop
ligand
specif
implic
sever
import
human
diseas
reagent
oligonucleotid
solvent
chemic
purchas
alfa
aesar
sigmaaldrich
use
suppli
without
purif
tlc
analysi
carri
silica
gel
merck
visual
nm
hplc
analysi
purif
perform
use
two
differ
hplc
water
system
combin
delta
pump
uvvi
detector
fraction
collector
iii
prepar
analyt
agil
system
seri
analyt
analyt
column
xselect
csh
phenylhexyl
mm
mm
water
prepar
column
xselect
csh
prep
mm
mm
water
flow
mlmin
analyt
mlmin
prepar
analyt
analysi
use
follow
method
aqueou
solvent
trifluoroacet
acid
water
organ
solvent
acetonitril
method
mlmin
isocrat
flow
min
aqueou
solvent
gradient
aqueou
gradual
aqueou
min
end
isocrat
flow
min
prepar
purif
use
follow
method
b
aqueou
solvent
trifluoroacet
acid
water
organ
solvent
acetonitril
method
b
mlmin
isocrat
flow
min
aqueou
solvent
gradient
aqueou
gradual
aqueou
min
end
isocrat
flow
min
nmr
spectra
record
bruker
advanc
mhz
spectromet
potentiometr
titrat
made
radiomet
titralab
titrat
system
uvvi
spectra
run
varian
cari
scan
spectrophotomet
quartz
cuvett
appropri
path
length
cm
emiss
spectra
record
perkinelm
ls
instrument
synthes
accord
publish
new
ligand
analyz
hplc
see
support
inform
hplc
puriti
data
confirm
puriti
yield
darkviolet
solid
mp
dec
nmr
mhz
dd
j
hz
dd
j
hz
nmr
mhz
anal
calcd
c
h
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
dd
j
hz
dd
j
hz
nmr
mhz
anal
calcd
c
h
br
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
j
hz
j
hz
bs
nmr
mhz
anal
calcd
c
h
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
j
hz
j
hz
bs
nmr
mhz
anal
calcd
c
h
br
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
bs
nmr
mhz
anal
calcd
c
h
br
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
j
hz
j
hz
nmr
mhz
anal
calcd
c
h
cl
n
found
c
h
n
yield
darkviolet
solid
mp
dec
nmr
mhz
j
hz
j
hz
nmr
mhz
anal
calcd
c
h
n
found
c
h
n
compound
mmol
dissolv
ml
n
mixtur
stir
heat
microwav
reactor
accord
close
vessel
protocol
psi
w
min
result
green
solut
cool
rt
induc
precipit
product
result
deepgreen
powder
filter
wash
water
afford
yield
hplc
prepar
purif
eluent
final
trifluoroacetatechlorid
anion
exchang
addit
ml
hcl
yield
trihydrochlorid
deepgreen
solid
mp
dec
nmr
mhz
bs
bs
nmr
mhz
anal
calcd
c
h
cl
n
found
c
h
n
yield
darkviolet
crystal
mp
dec
nmr
mhz
dd
j
hz
dd
j
hz
nmr
mhz
anal
calcd
c
h
n
found
c
h
n
yield
darkviolet
crystal
mp
dec
nmr
mhz
bs
bs
bs
nmr
mhz
anal
calcd
c
h
br
n
found
c
h
n
oligonucleotid
use
studi
sigmaaldrich
milan
itali
fluoresc
melt
curv
equimolar
amount
compound
ad
fam
tamra
oligonucleotid
um
fold
lithium
cacodyl
buffer
supplement
potassium
mm
stabil
sampl
process
lightcycl
ii
roch
milan
itali
lightcycl
roch
milan
itali
oligonucleotid
melt
monitor
observ
emiss
temperatur
rang
gradient
melt
profil
normal
previous
defin
temperatur
correspond
fraction
normal
fluoresc
cd
analysi
oligonucleotid
dilut
final
concentr
lithium
cacodyl
buffer
mm
ph
kcl
mm
anneal
step
min
dna
sampl
gradual
cool
room
temperatur
compound
ad
stock
final
concentr
cd
spectra
record
chirascanplu
appli
photophysis
leatherhead
uk
equip
peltier
temperatur
control
use
quartz
cell
mm
optic
path
length
instrument
scan
speed
nmmin
wavelength
rang
nm
report
spectrum
sampl
repres
averag
scan
baselinecorrect
signal
contribut
due
buffer
observ
ellipt
convert
mean
residu
ellipt
deg
mol
ellip
determin
tm
spectra
record
temperatur
rang
temperatur
increas
tm
valu
calcul
accord
van
hoff
equat
appli
twostat
transit
fold
unfold
state
assum
heat
capac
fold
unfold
state
taq
polymeras
stop
assay
carri
previous
briefli
label
primer
anneal
templat
support
inform
tabl
lithium
cacodyl
buffer
presenc
absenc
kcl
mm
heat
min
gradual
cool
room
temperatur
specifi
sampl
incub
nm
primer
extens
conduct
u
amplitaq
gold
dna
polymeras
appli
biosystem
carlsbad
california
usa
min
reaction
stop
ethanol
precipit
primer
extens
product
separ
denatur
gel
final
visual
phosphorimag
typhoon
fla
oligonucleotid
heatdenatur
fold
mm
kcl
mm
trimethylammonium
acet
tmaa
ph
overnight
room
temperatur
oligonucleotid
dilut
final
concentr
incub
test
compound
ratio
dna
compound
overnight
sampl
analyz
direct
infus
electrospray
ioniz
esi
xevo
qtof
mass
spectromet
water
manchest
uk
inject
automat
perform
agil
infin
hplc
agil
technolog
santa
clara
ca
us
equip
auto
sampler
carri
buffer
tmaa
mm
absenc
potassium
carri
buffer
allow
dilut
salt
ms
analysi
decreas
signal
suppress
sampl
typic
inject
analysi
electrospray
capillari
kv
sourc
desolv
temperatur
respect
sampl
cone
v
paramet
ensur
minim
fragment
dna
complex
instrument
calibr
use
mgml
solut
sodium
iodid
addit
use
lockspray
analysi
provid
typic
ppm
mass
accuraci
intern
standard
lockspray
consist
solut
leuenkephalin
acetonitrilewat
vv
contain
formic
acid
bind
affin
calcul
experi
use
reconstructedion
chromatogram
area
speci
calcul
masslynx
analysi
made
possibl
experiment
design
use
hplc
system
inject
sampl
mass
spectromet
bind
affin
calcul
follow
formula
ba
ba
bind
affin
chromatogram
area
bound
dna
chromatogram
area
free
compris
dna
one
two
bound
ligand
present
signal
charg
state
use
free
bound
htel
dna
cmyc
charg
state
ltriii
charg
state
charg
state
ltriv
free
dna
mono
dipotassium
adduct
includ
calcul
stoichiometr
calcul
oligonucleotid
fold
mm
kcl
mm
tmaa
ph
overnight
rt
oligonucleotid
dilut
final
concentr
incub
test
compound
ratio
analyz
esim
spr
perform
biacor
platform
ge
healthcar
ltriii
ltriv
htel
oligonucleotid
heat
min
cool
room
temperatur
allow
fold
immobil
perform
hepeskcl
run
buffer
hepe
ph
kcl
mm
edta
steptavidin
coat
surfac
sa
sensor
chip
biacor
oligonucleotid
dilut
hepeskcl
run
buffer
concentr
nm
inject
reach
respons
around
ru
flow
cell
left
empti
allow
refer
subtract
cexndi
bind
analysi
perform
flow
rate
contact
time
dissoci
time
hepeskcl
buffer
sensorgram
obtain
concentr
rang
nm
compound
inject
chip
surfac
regener
glycin
mm
ph
solut
ge
healthcar
sensorgram
correct
buffer
inject
respons
data
fit
bind
model
rmax
initi
paramet
set
theoret
calcul
rmax
use
biaevalu
softwar
ge
healthcar
experi
perform
independ
least
twice
instanc
valu
indic
good
fit
oligonucleotid
gelpurifi
use
prepar
desaltedlyophil
form
oligonucleotid
atp
polynucleotid
kinas
purifi
microspin
column
ge
healthcar
europ
next
resuspend
lithium
cacodyl
mm
ph
kcl
mm
heatdenatur
fold
reaction
label
gquadruplex
fold
oligonucleotid
pmolsampl
increas
amount
compound
nm
perform
h
resuspens
buffer
sampl
react
cl
h
reaction
stop
ethanol
precipit
resuspend
either
kept
ice
treat
min
piperidin
complet
strand
scission
accord
maxam
gilbert
protocol
sampl
lyophil
resuspend
formamid
gel
load
buffer
heat
min
reaction
product
analyz
denatur
polyacrylamid
gel
visual
typhoon
fla
phosphorimag
analysi
ge
healthcar
promot
activ
live
cell
presenc
monitor
cell
obtain
nih
aid
reagent
program
divis
aid
niaid
nih
dr
satoh
cell
line
deriv
helatatiii
transfect
control
ltr
promot
cell
seed
plate
ml
fb
medium
supplement
geneticin
select
antibiot
mgml
life
technolog
monza
itali
incub
overnight
cell
next
treat
increas
concentr
nm
incub
h
cell
wash
pb
resuspend
pb
evalu
mean
egfp
fluoresc
total
event
acquir
sampl
lr
instrument
use
fac
diva
softwar
bd
bioscienc
analyz
flow
jo
tree
star
cell
debri
dead
cell
exclud
analysi
gate
forward
scatter
fsc
versu
side
scatter
ssc
quantifi
estim
cytotox
luciferas
assay
ltr
region
wt
insert
promoterless
luciferas
report
vector
promega
italia
itali
previous
assess
luciferas
activ
human
embryon
kidney
cell
seed
plate
cellswel
h
later
cell
transfect
ngwell
use
transfect
reagent
miru
bio
llc
madison
wi
usa
accord
manufactur
protocol
h
cell
treat
h
variou
concentr
luciferas
activ
measur
use
britelit
plu
report
gene
assay
system
perkinelm
inc
milan
itali
victor
multilabel
plate
reader
perkinelm
inc
milan
itali
accord
manufactur
instruct
cell
lyse
ripa
buffer
mm
trishcl
ph
mm
nacl
igep
sd
protein
concentr
determin
bca
assay
thermo
scientif
pierc
monza
itali
luciferas
signal
subsequ
normal
total
protein
content
accord
manufactur
protocol
http
itapromegacompdfresourcespubhubcellnotesnormalizinggeneticreporterassay
infect
measur
use
tzmbl
report
cell
line
obtain
nih
aid
reagent
program
divis
aid
niaid
nih
dr
jc
kapp
dr
x
wu
tranzym
inc
tzmbl
hela
cell
line
stabli
express
larg
amount
contain
integr
copi
luciferas
gene
control
promot
tzmbl
grown
dmem
supplement
fb
cell
cellswel
seed
plate
grown
overnight
permit
adher
prior
treatment
viral
infect
cell
next
infect
strain
bal
strain
moi
treat
serial
dilut
test
compound
incub
h
cell
wash
pb
product
assess
follow
ltrluciferas
signal
use
britelit
plu
report
gene
assay
system
perkinelm
waltman
usa
accord
manufactur
protocol
cytotox
test
compound
test
parallel
antivir
report
assay
mtt
cytotox
concentr
defin
concentr
test
compound
abl
reduc
absorb
mockinfect
cell
inhibitori
concentr
defin
concentr
test
compound
inhibit
ltrluciferas
signal
select
index
si
rel
effect
test
compound
inhibit
viral
replic
compar
induc
cell
death
valu
therapeut
window
tw
concentr
rang
compound
show
antivir
activ
parallel
less
cytotox
tzmbl
cell
cellswel
seed
plate
grown
overnight
permit
adher
prior
treatment
viral
infect
cell
next
infect
moi
incub
compound
nm
refer
compound
ds
sigmaaldrich
azt
sigmaaldrich
ad
differ
hour
h
pi
h
cell
wash
pb
product
assess
follow
ltrluciferas
signal
use
britelit
plu
report
gene
assay
system
perkinelm
waltman
usa
accord
manufactur
protocol
dft
calcul
perform
gaussian
revis
softwar
gasphas
geometri
optim
carri
use
p
basi
set
atom
